Health Industry Watch
SEE OTHER BRANDS

Your healthcare and wellness news reporter

Health Industry Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Industry Watch.

Press releases published on May 6, 2025

Arcutis Announces First Quarter 2025 Financial Results and Provides Business Update

Arcutis Announces First Quarter 2025 Financial Results and Provides Business Update

Q1 2025 net product revenue for ZORYVE® (roflumilast) was $63.8 million, a 196% increase compared to Q1 of 2024, and a 2% decrease compared to Q4 of 2024, due to typical first-quarter deductible resets and insurance changes, and excluding the non-recurring …

Kentucky Marks a Milestone in Medical Marijuana Legislation: A Story of Hope and Transformation

Kentucky Marks a Milestone in Medical Marijuana Legislation: A Story of Hope and Transformation

Kentucky's new Medical Cannabis Card Program offers patients in Beaver Dam and statewide legal access to lab-tested medical marijuana, inspiring hope. BEAVER DAM, KY, UNITED STATES, May 6, 2025 /⁨EINPresswire.com⁩/ -- In a groundbreaking move that echoes …

SOUND Behavioral Health Launches “Orange Door” Campaign for Mental Health Awareness Month

SOUND Behavioral Health Launches “Orange Door” Campaign for Mental Health Awareness Month

SEATTLE, May 06, 2025 (GLOBE NEWSWIRE) -- This May, in recognition of Mental Health Awareness Month, SOUND Behavioral Health is proud to launch the “Orange Door” campaign—a bold new initiative designed to raise awareness around the growing need for mental …

Late-Breaking Interim STENOVA Data Presented at Digestive Disease Week® 2025 Demonstrate Potential of AGMB-129 in Fibrostenosing Crohn’s Disease

Late-Breaking Interim STENOVA Data Presented at Digestive Disease Week® 2025 Demonstrate Potential of AGMB-129 in Fibrostenosing Crohn’s Disease

Antwerp, Belgium, May 6, 2025 – Agomab Therapeutics NV (“Agomab”) today announced late-breaking interim data from the ongoing STENOVA1 Phase 2a clinical trial for AGMB-129, an oral gastro-intestinal (GI)-restricted small molecule inhibitor of ALK5 (TGF-β  …

Nexalin Technology Announces Closing of Previously Announced $5.0 Million Underwritten Public Offering

Nexalin Technology Announces Closing of Previously Announced $5.0 Million Underwritten Public Offering

HOUSTON, May 06, 2025 (GLOBE NEWSWIRE) --  Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”), the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, today announced the closing of its previously announced …

Annual NMDP(SM) Gala in New York City Raises Over a Half Million Dollars, Enabling More Patients to Receive Life-Saving Cell Therapy

Annual NMDP(SM) Gala in New York City Raises Over a Half Million Dollars, Enabling More Patients to Receive Life-Saving Cell Therapy

MINNEAPOLIS, May 06, 2025 (GLOBE NEWSWIRE) -- NMDPSM hosted its annual gala in New York on Thursday, May 1, raising $525,000-- funds which will support patient financial assistance and innovative cell therapy research to improve post-transplant outcomes …

Real-Time E-Healthcare System Market Poised for Significant Growth to Reach USD 64,362.0 Million by 2035 | FMI

Real-Time E-Healthcare System Market Poised for Significant Growth to Reach USD 64,362.0 Million by 2035 | FMI

Real-Time E-Healthcare System Market grows as demand surges for instant medical data access, remote monitoring, and smart health tech. NEWARK, DE, UNITED STATES, May 6, 2025 /⁨EINPresswire.com⁩/ -- The global real-time e-healthcare system market is on a …

Cosmos Health Receives Additional 180-Day Compliance Period from Nasdaq

Cosmos Health Receives Additional 180-Day Compliance Period from Nasdaq

CHICAGO, May 06, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R…

Hawaii Medical College Launches Basic Nurse Aide Program to Meet Growing Healthcare Demand

Hawaii Medical College Launches Basic Nurse Aide Program to Meet Growing Healthcare Demand

HONOLULU, HI, UNITED STATES, May 5, 2025 /⁨EINPresswire.com⁩/ -- Hawaii Medical College is proud to announce the launch of its Basic Nurse Aide Program, designed to provide students with the essential skills and training required to enter the healthcare …

Global Nephrology and Urology Incontinence Devices Market to Witness Steady Growth at 4.1% CAGR Through 2032 | FMI

Global Nephrology and Urology Incontinence Devices Market to Witness Steady Growth at 4.1% CAGR Through 2032 | FMI

Rising cases of incontinence and aging population drive growth in the nephrology and urology incontinence devices market globally. NEW, DE, UNITED STATES, May 6, 2025 /⁨EINPresswire.com⁩/ -- The global nephrology and urology incontinence devices market is …

Angioedema Clinical Trial Pipeline Analysis Demonstrates 15+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight

Angioedema Clinical Trial Pipeline Analysis Demonstrates 15+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight

New York, USA, May 06, 2025 (GLOBE NEWSWIRE) -- Angioedema Clinical Trial Pipeline Analysis Demonstrates 15+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight Angioedema is a rapid swelling of the deeper …

R3 Stem Cell Wins 2025 Award for Leading Innovators in Regenerative Cell Therapy

R3 Stem Cell Wins 2025 Award for Leading Innovators in Regenerative Cell Therapy

SCOTTSDALE, AZ, UNITED STATES, May 5, 2025 /⁨EINPresswire.com⁩/ -- R3 Stem Cell has won the 2025 Award for Leading Innovators in Regenerative Cell Therapy. As the global leader in stem cell and exosome treatments, this makes the fifth straight year that R3 …

Avadel Pharmaceuticals Announces Favorable Ruling in Appeal of Delaware Court Injunction

Avadel Pharmaceuticals Announces Favorable Ruling in Appeal of Delaware Court Injunction

- With this ruling, Avadel can seek and be granted FDA approval for LUMRYZ in Idiopathic Hypersomnia - - Federal Circuit decision permits new clinical trials and further development of LUMRYZ™ for the treatment of indications beyond narcolepsy - DUBLIN, …

IDCRAFT GmbH officially launched: A new specialist for RFID and Auto-ID hardware solutions

IDCRAFT GmbH officially launched: A new specialist for RFID and Auto-ID hardware solutions

Our portfolio includes RFID reader modules, stationary readers, transponders and labels – perfectly suited for Auto-ID applications. NEUHOFEN, RHINELAND-PALATINATE, GERMANY, May 6, 2025 /⁨EINPresswire.com⁩/ -- ]With the founding of IDCRAFT GmbH, a new …

Guided Spinal Navigation Landmark Surgery Opens the Door to Cost-Effective 3D Augmented Reality

Guided Spinal Navigation Landmark Surgery Opens the Door to Cost-Effective 3D Augmented Reality

Salt Lake City, May 06, 2025 (GLOBE NEWSWIRE) -- A groundbreaking surgical procedure was successfully performed on a small island in the Mediterranean, marking a significant advancement in spinal surgery. At Hospital Son Llàtzer in Mallorca, Spain, Dr. …

Girl Scouts of Northern California Unveil New HUB At Camp Bothin in Fairfax

Girl Scouts of Northern California Unveil New HUB At Camp Bothin in Fairfax

The New Community Space Honors Local Leadership, Community Connection, and Outdoor Adventure in Marin County ALAMEDA, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- On Saturday, May 3, Girl Scouts of Northern California officially celebrated the ribbon cutting …

Beacon Therapeutics Announces Positive Phase 2 Interim 6-Month Data from DAWN Trial of Laru-zova in Patients with X-linked Retinitis Pigmentosa (XLRP) at ARVO 2025

Beacon Therapeutics Announces Positive Phase 2 Interim 6-Month Data from DAWN Trial of Laru-zova in Patients with X-linked Retinitis Pigmentosa (XLRP) at ARVO 2025

Data showed improvements across several key measures of visual function, including low luminance visual acuity and microperimetry Laru-zova was generally well-tolerated by DAWN participants at 6 months LONDON and CAMBRIDGE, Mass., May 06, 2025 (GLOBE …

Pasithea Therapeutics Announces Pricing of $5 Million Public Offering

Pasithea Therapeutics Announces Pricing of $5 Million Public Offering

MIAMI, May 06, 2025 (GLOBE NEWSWIRE) -- Pasithea Therapeutics, Corp. (“Pasithea,” or the “Company”) (Nasdaq: KTTA; KTTAW), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic MEK inhibitor, for the treatment of …

BrandSpark and Newsweek Announce 2025 Best New Product Award Winner: Premom’s Premium Prenatal Multivitamin

BrandSpark and Newsweek Announce 2025 Best New Product Award Winner: Premom’s Premium Prenatal Multivitamin

Darien, Illinois, May 06, 2025 (GLOBE NEWSWIRE) -- Fertility and pregnancy support pioneer, Premom, is proud to announce that its Premium Prenatal Multivitamin has been awarded the prestigious 2025 Best New Product Award as part of the 17th annual Best New …

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS 6 May 2025 at 18.00 EEST          Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion Corporation has received a disclosure …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service